Trial intelligence / Profile preview

Dexmedetomidine for Renal Function in Kidney Transplant

NCT02874378Unknown

Sponsor
First Affiliated Hospital of Xi'an Jiaotong University
Start
Oct 2016
Primary completion
May 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in kidney failure (ESRD) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Cystatin C level at 2 weeks. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

kidney failure (ESRD)

Beyond the preview

Go deeper on NCT02874378.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02874378.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call